Trial · NCT06973902
Registered outcomes15
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 15 of 15
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | New York Heart Association class variation | From enrollment to the end of follow-up, 12 months | The proportion of subjects with clinical response to CCM therapy at 12 months, defined as a reduction of at least 1 class of the New York Heart Association Classification of the functional status of the heart (minimum value I, better outcome, and maximum value IV, worse outcome) |
| Secondary | Hospitalizations | From enrollment to the end of follow-up, 12 months | Change in the number of hospitalizations, visits to the Emergency Department, or access to day hospital facilities for more than 4 hours (e.g., by intravenous infusion of cardiac inotropic drugs) compared to the year before the study. |
| Secondary | Minnesota LIVING WITH HEART FAILURE Questionnaire score variation | From enrollment to the end of follow-up, 12 months | Change in the quality-of-life score estimated with the "Minnesota LIVING WITH HEART FAILURE Questionnaire" MLHFQ (minimum value 0, better outcome, and maximum value 105, worse outcome), |
| Secondary | 6MWT variation | From enrollment to the end of follow-up, 12 months | Change in walk distance between baseline and end of follow-up in the walk test (6MWT) |
| Secondary | NT-proBNP variation | From enrollment to the end of follow-up, 12 months | Change in NT-proBNP level between baseline and end of follow-up |
| Secondary | LVESV change | From enrollment to the end of follow-up, 12 months | The proportion of subjects with LVESV decreased by ≥ 15% on echocardiography at end-of-follow-up compared to preimplantation |
| Secondary | VTI change | From enrollment to the end of follow-up, 12 months | The proportion of subjects with increased integral velocity time (VTI) ≥ 20% between preimplantation and end-of-follow-up echocardiography, |
| Secondary | LVEF change | From enrollment to the end of follow-up, 12 months | The proportion of subjects with a 20% increase in ejection fraction (LVEF) between preimplantation and end-of-follow-up echocardiography |
| Secondary | MR change | From enrollment to the end of follow-up, 12 months | The proportion of subjects with progression or, conversely, improvement in Mitral Regurgitation (M.R.; classified as mild, moderate, or severe). |
| Secondary | CRT implant | From enrollment to the end of follow-up, 12 months | The proportion of subjects who, during follow-up, will be evolved to cardiac resynchronization system (CRT) implantation |
| Secondary | LVAD implant | From enrollment to the end of follow-up, 12 months | The proportion of subjects who, during follow-up, will be evolved to left ventricular assist device (LVAD) implantation, |
| Secondary | Cardiac Transplant | From enrollment to the end of follow-up, 12 months | The proportion of subjects who will have received a cardiac transplant during follow-up |
| Secondary | HF death | From enrollment to the end of follow-up, 12 months | The proportion of subjects who will die from H.F. during follow-up |
| Secondary | AE | From enrollment to the end of follow-up, 12 months | Rate of all procedure-related adverse events. |
| Secondary | Re-Operation | From enrollment to the end of follow-up, 12 months | Rate of re-operations (lead revision/replacement/infection) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06973902/registered